test

Her2, c-kit EGFR and akt1 Expression in Carcinosarcomas of Female Genital Tract: Prognostic Factors or Potential Markers for Targeted Therapies

Conditions

Gynecological Cancers

Trial Phase

Trial Purpose and Description

Trial Purpose

Participation Guidelines

Age:
18 Years and older
Gender:
Female

Eligibility Criteria

Sponsor:
Yale
Dates:
April 2011
Last Updated:
Study HIC#:
1104008301

Clinicaltrials.gov ID: Yale8218761